The Merit Medical Systems Inc. (NASDAQ:MMSI) is going up by 0.36% in today’s trading session, a rise equivalent to 0.1% of the stock’s price from yesterday’s market close. A news came out on 11/21/19 stating that Merit Medical Receives FDA Breakthrough Device Designation for WRAPSODY(TM) Endovascular Stent Graft System by WSJ. The lowest point that the shares touched during the trading session was $27.68, while the peak of the day was recorded at a share price of $28.24. MMSI finished the previous session at $28.00 according to the data provided by Barchart, while the trading volume was observed to be $595514.

In the 100 days of trading, MMSI managed to top a 33.51% Moving average. Additionally, Merit Medical Systems Inc. shares have achieved a 52-week range between 19.50 and 64.03 alongside 100 days raw stochastic set at 34.22%.

The number of shares outstanding, according to the fundamentals of the company, is set at 55.54M, equal to the value of $1.56B in market capitalization. In the last 30 days, Merit Medical Systems Inc. shares went down by -1.41%, adding 28.42 to growth in value, on top of a +15.55% boost since 11/01/19.

Merit Medical Systems Inc. (NASDAQ:MMSI) Analyst’s Estimates

Merit Medical Systems Inc. (MMSI) could record at least $0.34 per share in quarterly earnings in the upcoming report on 02/20/2020, a number that would actually represent an increase of 1.59 YOY.

According to the average analyst rating, Merit Medical Systems Inc. would be rated as Overweight. Out of 9 different analysts monitoring MMSI stock, 5 analysts rate the stock as a BUY, 3 suggest to give the rating of HOLD, 0 indicate that MMSI is an OVERWEIGHT, 0 rated the stock as a SELL, and 1 analyst believes that the stock should be rated as UNDERWEIGHT.

On September 24, 2019, the stock earned a Initiated rating due to a new analyst call from Oppenheimer, while analysts from Raymond James believe that the stock is set at Mkt Perform from Outperform, as concluded on September 10, 2019. Wells Fargo, is still rather wary about the stock, deciding to keep the rating at Market Perform as confirmed through a call on July 26, 2019.

Needham, on the other hand, provided a rather enthusiastic opinion on the rating, concluded in an analyst call on October 02, 2018, giving the stock a Buy rating.

MMSI Key Ratios To Watch:

Taking in account the profitability of the Company, gross profit margin of +44.67% has been attained, while the operating margin has been recorded at +7.25%. The firm is also showcasing profitability through returns on assets in the company’s ownership, with ROA set at 3.08%. Beta value of the stock is recorded at 1.09. Additionally, Merit Medical Systems Inc. is recording price volatility of 2.54% for the period of the last seven days and 5.89% in the last 30 days.

Merit Medical Systems Inc. (NASDAQ:MMSI) Technical Outlook

For the period of the last 50 days, Merit Medical Systems Inc. had its Raw Stochastic average set at 64.50% for the latest technical analysis. In comparison to the period of the last 20 days, the present Raw Stochastic average for the last 50 days poses as improvement, set at 90.41%. Stochastic %K for Merit Medical Systems Inc., with the last 20 days included, was set at 94.06%, having Stochastic %D topping 94.09%. Based on the previous performance of the company for the mentioned period, there are more than several recorded moving trends. When it comes to the period of the last 12 months, accounting the time for year-to-date, price performance appears to be discouraging for Merit Medical Systems Inc. stocks with recording -49.83% in metrics.

Merit Medical Systems Inc. Insider Watch:

Similarly, 100.44% of the company’s float is held by institutions – and there are 358 institutions in total holding shares of this company. The top three institutional holders of MMSI stocks are: Blackrock Inc. with ownership of $247.07 million, which is approximately 8111167 of the company’s shares; Vanguard Group, Inc. (The), holding 5632587 shares of the stock with an approximate value of $171.57 million; and ArrowMark Colorado Holdings LLC, currently with more than 4085775 shares of the company valued at $124.45 million. Positions in Merit Medical Systems Inc. stocks held by institutional investors has been changing actively in the past six months, a period during which there were 7 insider purchases amounting to 133771 shares. Similarly, there were 7 sale transactions amounting to 262347 shares, with the net shares purchased during the last six months reaching -128,576.